ClinVar

Description

Variant classified as Uncertain Significance - Favor Pathogenic. The p.Thr127Ala variant was identified with a canonical splice variant (phase not determined) in another family with two relatives with a neurodevelopmental phenotype consisting of profound global developmental delays, abnormal muscle tone, and intractable seizures (Gleeson et al, unpublished data). It was also identified in this family in a compound heterozygous state with a loss of function variant in two siblings with profound global developmental delays, microcephaly, intractable seizures, hypotonia, hypoplasia of the corpus callosum, and cortical vision impairment by the Broad Institute Rare Genomes Project. In vitro functional studies of p.Thr127Ala demonstrate a reduction of protein levels in cultured cells (Joseph Gleeson laboratory, UC San Diego, unpublished data) although this observation may not represent disrupted biological function. This variant has been identified in 0.014% of non-Finnish European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Computational prediction tools and amino acid conservation analysis suggest that the p.Thr127Ala variant may impact the protein, though this information is not predictive enough to determine pathogenicity through a protein sequence change. Currently, there is moderate evidence to support an association between PPIL1 and a severe neurodevelopmental phenotype. In summary, while there is suspicion for a pathogenic role, the clinical significance of the p.Thr127Ala variant remains uncertain. ACMG/AMP Criteria applied: PS3_Moderate, PM2_Supporting, PP3.